Cesare Ferrari

JUNE 7, 2024

If you are a medical sales rep working for a pharma or a medical device company, you might already have experienced the frustration of not convincing a prospect about your product. Targeting these prospects, they get some “easy sales” and become more comfortable with the product.

Medical sales 52

Medical sales Sales Medical Prospecting 52

pharmaphorum

JULY 8, 2022

The move comes as Sobi’s haematology business – centred largely around a partnership with Sanofi in haemophilia therapies – has come under competitive pressure from new therapies like Roche’s Hemlibra (emicizumab).

Competition 52

Competition Prospecting Marketing Sales 52

Toolyt

NOVEMBER 11, 2021

The sales job is a highly competitive field, but the Medical Sales Reps job is more challenging. It is a rare arena where the prospects have more knowledge about medicines and diseases than the seller. You should be well aware of the medicines your company sells. Effects And Counter-effect Of Drugs & Medicines.

Medical sales reps 52

Medical sales reps Medical sales Doctors Training 52

Pharmaceutical Technology

APRIL 11, 2023

Orkambi is an oral medicine that uses a fixed combination dose of lumacaftor and ivacaftor. The FDA initially granted Orkambi approval in 2015 as the first medicine to treat the underlying cause of CF for individuals aged 12 or older with two copies of the F508del mutation.

Medicine 98

Medicine Patients Safety Prospecting 98

Healthcare Success

MAY 24, 2022

Hospitals, health systems, and medical practices must evolve to meet these changing needs to remain competitive or risk falling behind. Increase your strategic advantage to attract healthcare consumers in an increasingly competitive marketplace. It only takes 5 seconds to lose a prospective consumer. Build your brand.

Healthcare 102

Healthcare Healthcare Marketing Physicians 102

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . It is all about what you can get at the lowest cost,” says Dr. Raymond Cross, director of the inflammatory bowel disease program at University of Maryland’s School of Medicine, Baltimore.

Marketing 104

Marketing Physicians Competition Patients 104

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. UR Medicine, Rochester, New York.

Networking 52

Networking Healthcare Healthcare Competition 52

Quantified

MARCH 28, 2023

Confidence in your products, your brand, and your ability to find the right solution to a prospective client’s problems are all crucial parts of building trust with clients. Of the B2B prospects that salespeople lose, two-thirds leave because the prospects think the salesperson is indifferent and inauthentic.

Sales 52

Sales Training Prospecting Competition 52

Healthcare Success

JULY 5, 2022

Not only are doctors and decision-makers difficult to reach—and even more difficult to persuade—you have to contend with a ton of competition. Here are two ways to define your doctor audience: Target your best prospects Enhance your database to target more precisely. Target Your Best Prospects. doctors are treating most often.

Doctors 59

Doctors Physicians Marketing Prospecting 59

Pharmaceutical Technology

JANUARY 22, 2023

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. Dr. Jerry Mendell, MD, professor of paediatrics and neurology at the Ohio State University College of Medicine, is optimistic for its approval and says the drug has a good safety profile. In clinical trials, the drug showed a 3.8-point

FDA 126

FDA Safety Pharmaceutical Patients 126

Pharmaceutical Technology

APRIL 26, 2023

The company targets disease through mechanisms in the extracellular matrix (ECM), where Albatroz’s medicines target and degrade a protein complex, Calnexin. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Marketing 102

Marketing Pharmaceutical Manufacturing Prospecting 102

Evolve Your Success

APRIL 11, 2023

My partner is an emergency medicine physician. That’s what we see in medicine every day. Medical Device Sales: What we see in medicine every day is clinicians are evidence-based. My company standpoint is, “Online is the new prospecting tool.” Online is the new prospecting tool. I embrace it too.

Sales 130

Sales Medical Medical sales Media 130

Medico Reach

APRIL 21, 2022

And in this competitive digital era, email marketing is still one of the best strategies to boost your sales. However, handling competition is challenging whether you’re a marketer or a medical facility owner. For instance, your healthcare brand has invented a revolutionary medicine to treat a serious ailment.

Marketing 52

Marketing Healthcare Healthcare Sales 52

Pharmaceutical Technology

DECEMBER 19, 2022

To build an advanced pharmaceutical manufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceutical manufacturers. Several region-specific nonprofits and government organizations also play a significant role in the life cycle of an SME.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

Pharmaceutical Technology

FEBRUARY 17, 2023

As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

FDA 115

FDA Side effects Pharmacology Patients 115

pharmaphorum

SEPTEMBER 22, 2022

After a torrid couple of years, Biogen can be forgiven for making the most of new data on its tofersen drug for amyotrophic lateral sclerosis (ALS) – with an elevated status among its pipeline prospects largely as a result of failures in other programmes.

FDA 52

FDA Sales Prospecting Patients 52

Pharmaceutical Technology

MAY 5, 2023

The UK government, the National Health Service (NHS) England, and the Association of the British Pharmaceutical Industry (ABPI) have opened negotiations for a new Voluntary scheme for Branded Medicines Pricing and Access (VPAS). These negotiations began after the government held a debate on the matter on May 3.

Government 52

Government Medicine Pharmaceutical Medical sales 52

Pharmaceutical Technology

APRIL 24, 2023

Everest Medicines launched its immunoglobulin A (IgA) nephropathy drug Tarpeyo (Nefecon) (budesonide) in China’s Hainan Boao Pilot Zone, making it the first therapy available in this disease area. The China National Medical Products Administration (NMPA) accepted Everest Medicines’ New Drug Application for Tarpeyo in November 2022.

Medicine 52

Medicine Marketing Medical Prospecting 52

Medico Reach

JANUARY 7, 2025

Similarly, for chiropractors, staying informed and engaged with these trends is key to staying ahead of the competition. In a competitive market with numerous healthcare products and services, these modalities can help you stand out, attract more clients, and enhance your professional offering.

Healthcare 52

Healthcare Healthcare Marketing Education 52

Map My Customers

AUGUST 2, 2022

With a demanding schedule and fierce competition, a solid foundation is critical for becoming a successful medical sales rep.   Unless you got your undergrad degree in medicine or science, you might be missing out on crucial context that could be costing you bigger deals. Especially in device and equipment sales.)

Medical sales reps 79

Medical sales reps Medical sales Sales Medical 79

European Pharmaceutical Review

DECEMBER 22, 2022

Eight bispecific antibodies have been approved by the European Medicines Agency, including four novel products in 2022. Innovative bsAb designs, as highly targeted medicines, hold the promise of changing the way we treat cancer and other diseases. 1 Such rapid expansion provides opportunities for significant therapeutic advancement.

Manufacturing 98

Manufacturing Leads Engineering Pharmaceutical 98

Pharmaceutical Technology

MAY 4, 2023

Furthermore, in April 2023, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) gave a positive opinion in support of the vaccine’s approval. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

FDA 64

FDA Safety Medicine Prescription 64

Clarify Health

MARCH 1, 2023

For small independent practices, the prospect of financial rewards alone is not enough to motivate engagement. This delicate balance taps into physician’s natural competitive tendencies, but bounds these tendencies in shared goals and joint commitment. Manuscript in Preparation]. [3] 3] Emanuel, Ezekiel, et al.,

Physicians 52

Physicians Prescription Medicine Management 52

Medical Sales News

MAY 27, 2021

Their responsibilities may include; visit prospects on location, manage leads and customers within a defined territory, provide product demonstrations, communicate between sales, marketing, and support teams, analyze field sales data assisting with strategic planning and implementation, and much more.

Medical sales 52

Medical sales Sales Medical Doctors 52

Pharmaceutical Technology

MAY 10, 2023

On May 9, The Scottish Medicines Consortium approved the inclusion of Pfizer and Biohaven’s Vydura (rimegepant) into the Scottish National Health Services (NHS) for the acute treatment of migraines. Vydura is part of a new class of migraine medicines called gepants and it is the first to receive an approval for use on the NHS.

Medicine 52

Medicine Medical Prospecting Competition 52

Pharmaceutical Technology

MARCH 15, 2023

The biopharmaceutical company Pharming Group , based in the Netherlands, which develops innovative protein replacement therapies and precision medicines for multiple rare diseases, stated the HSBC acquisition of Silicon Valley Bank UK would allow it access to its $19m deposit and not bear any losses. in deposits. in deposits.

Medicine 59

Medicine Marketing Pharma Government 59

Pharmaceutical Technology

MAY 31, 2023

AMX0035, marketed as Relyvrio in the US and Abrioza in Canada, is currently awaiting approval on its marketing authorisation application (MAA) from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry.

Food and Drug Administration 52

Food and Drug Administration FDA Medicine Marketing 52

Pharmaceutical Technology

MAY 9, 2023

However, as donanemab’s approval prospects increase, it is an open question whether the drug’s prospects for Centers for Medicare & Medicaid Services (CMS) coverage are better than those of previously approved amyloid-targeting therapies.

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

MAY 9, 2023

However, as donanemab’s approval prospects increase, it is an open question whether the drug’s prospects for Centers for Medicare & Medicaid Services (CMS) coverage are better than those of previously approved amyloid-targeting therapies.

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

APRIL 16, 2023

This is an exciting prospect: oncology, and immuno-therapy in particular, is a driving force behind biotech R&D, with new cancer therapies and molecules accounting for nearly 40% 1 of the industry’s development pipeline. National Library of Medicine – Silicone Oil Induced Aggregation of Proteins 4. References 1.

Medical 52

Medical Medicine Patients Manufacturing 52

Zymewire

FEBRUARY 8, 2024

A b iotech company seemed to be the most efficient and robust way to translate these technologies into medicines so that we could t est their potential health benefits in patients , and we were in a unique position to be able to leverage the thriving biotech ecosystem in Boston.

Competition 52

Competition Leads Patients Marketing 52

Pharmaceutical Technology

MAY 2, 2023

Immatics also has a research collaboration with gene editing company Editas Medicine to advance its T cell therapies. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Manufacturing 52

Manufacturing Engineering Prospecting Competition 52

Pharmaceutical Technology

JANUARY 15, 2023

On November 30, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) awarded a Great Britain marketing authorization to Aurinia Pharmaceuticals’ Lupkynis (voclosporin) for the treatment of lupus nephritis. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Manufacturing 52

Manufacturing Pharmaceutical FDA Pharma 52

Pharmaceutical Technology

APRIL 24, 2023

This intersection will be remembered as one of the most significant achievements in science and medicine”. There are still possibilities that these types of nanoparticles could be used for a whole range of nucleic acid medicines, whether mRNA, DNA, or CRISPR Cas9… for different genetic diseases.

Pharmaceutical 59

Pharmaceutical Medicine Sales FDA 59

Pharmaceutical Technology

FEBRUARY 10, 2023

She has experience as the discipline coordinator for treatment planning for the Doctor of Dental Medicine program and is a member of the Board of Examiners (MRACDS) for the Royal Australasian College of Dental Surgeons. In Australia, these medicines are more restricted and oral quinolones can’t be prescribed to children.

Prescription 52

Prescription Doctors Patients Pharmaceutical 52

Pharmaceutical Technology

JUNE 2, 2023

A statement from the industry group PhRMA said, “CMS is reaffirming their plan to severely restrict patient access to FDA-approved medicines, leaving in place barriers to potentially life-changing treatment options for a devastating illness.” Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry.

Food and Drug Administration 52

Food and Drug Administration FDA Prospecting Patients 52

Pharmaceutical Technology

APRIL 17, 2023

In this programme, argenx is collaborating with 13 academic institutions worldwide, including NYU School of Medicine, Bern University and more. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Engineering 52

Engineering Food and Drug Administration FDA Prospecting 52